This microenvironment promotes the secretion of cytokines, such as TNF-α and IL-6, which impair insulin signaling by inhibiting the IRS-1/PI3K/Akt pathway, contributing substantially to the systemic insulin resistance observed in the Ob-Veh and HE-Ob-Veh groups [64,65]. The gene discussed is IL6; the disease is Insulin resistance.